tyloxapol has been researched along with Fatty Liver in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buhman, KK; Cheng, JX; Fast, AM; Lee, B; Zhu, J | 1 |
Akita, M; Alpers, DH; Hokari, S; Inoue, I; Kanazawa, K; Katayama, S; Komoda, T; Koyama, I; Masuyama, T; Millán, JL; Nakamura, K; Nakano, T; Narisawa, S; Seo, M; Tanaka, K | 1 |
Averna, MR; Chen, Z; Fitzgerald, RL; Schonfeld, G | 1 |
3 other study(ies) available for tyloxapol and Fatty Liver
Article | Year |
---|---|
Intestine-specific expression of acyl CoA:diacylglycerol acyltransferase 1 reverses resistance to diet-induced hepatic steatosis and obesity in Dgat1-/- mice.
Topics: Animals; Detergents; Diacylglycerol O-Acyltransferase; Diet; Dietary Fats; Enterocytes; Fatty Liver; Female; Intestines; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Polyethylene Glycols; Transgenes; Triglycerides | 2010 |
Disruption of the murine intestinal alkaline phosphatase gene Akp3 impairs lipid transcytosis and induces visceral fat accumulation and hepatic steatosis.
Topics: Alkaline Phosphatase; Animals; Dietary Fats; Fatty Liver; Female; Intestinal Absorption; Intestine, Small; Intra-Abdominal Fat; Lipid Metabolism; Lipoprotein Lipase; Male; Mice; Polyethylene Glycols; Triglycerides | 2007 |
A targeted apolipoprotein B-38.9-producing mutation causes fatty livers in mice due to the reduced ability of apolipoprotein B-38.9 to transport triglycerides.
Topics: Animals; Apolipoprotein B-100; Apolipoproteins B; Base Sequence; Cells, Cultured; Cholesterol; Fatty Liver; Hepatocytes; Humans; Hypobetalipoproteinemias; Intestine, Small; Liver; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Transgenic; Phospholipids; Polyethylene Glycols; Polymerase Chain Reaction; Sequence Alignment; Sequence Homology, Nucleic Acid; Surface-Active Agents; Triglycerides | 2000 |